MPI will attend the JPMorgan Conference from 12-15 January 2015.

Please contact CEO Peter Buhl Jensen pbj@medical-prognosis.com

Venlighedsvej 1  DK-2970 Hoersholm Denmark  CVR: 28106351 IR@medical-prognosis.com

Innovating Prediction

          -Improving Cancer Survival


MPI is an international Biotech/IT company specializing in Precision Medicine by the creation of Biomarkers and development of Companion Diagnostics for the treatment of cancer.

Hør CEO Peter Buhl Jensen fortælle om MPI